Stereotaxis, Inc. (STXS)
1.72
-0.06
(-3.37%)
USD |
NYAM |
May 19, 16:00
1.72
0.00 (0.00%)
After-Hours: 20:00
Stereotaxis Research and Development Expense (Quarterly) : 2.397M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Myomo, Inc. | 1.623M |
| TransMedics Group, Inc. | 24.88M |
| CONMED Corp. | 16.33M |
| Escalon Medical Corp. | 0.0299M |
| IRIDEX Corp. | 0.949M |